Neurocrine Biosciences
NBIX
#1542
Rank
โ‚น944.07 B
Marketcap
โ‚น9,469
Share price
-0.07%
Change (1 day)
-17.01%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total assets

Total assets on the balance sheet as of December 2024 : โ‚น323.07 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total assets are โ‚น323.07 Billion. A companyโ€™s total assets is the sum of all current and non-current assets, such as inventories, cash and cash equivalents, properties and equipment.

Neurocrine Biosciences - Total assets on balance sheet (from 2001 to 2024)

Total assets by year

Year Total assets Change
2024-12-31โ‚น319.01 B17.86%
2023-12-31โ‚น270.67 B38.09%
2022-12-31โ‚น196.01 B27.07%
2021-12-31โ‚น154.25 B21.59%
2020-12-31โ‚น126.86 B36.22%
2019-12-31โ‚น93.13 B34.11%
2018-12-31โ‚น69.44 B33.02%
2017-12-31โ‚น52.20 B110.42%
2016-12-31โ‚น24.80 B-21.37%
2015-12-31โ‚น31.55 B104.84%
2014-12-31โ‚น15.40 B61.19%
2013-12-31โ‚น9.55 B-10.95%
2012-12-31โ‚น10.73 B46.6%
2011-12-31โ‚น7.31 B13.1%
2010-12-31โ‚น6.47 B96.95%
2009-12-31โ‚น3.28 B-42.15%
2008-12-31โ‚น5.68 B-47.68%
2007-12-31โ‚น10.85 B-37.09%
2006-12-31โ‚น17.25 B-20.61%
2005-12-31โ‚น21.74 B-3.32%
2004-12-31โ‚น22.48 B-11.01%
2003-12-31โ‚น25.26 B97.68%
2002-12-31โ‚น12.78 B-23.52%
2001-12-31โ‚น16.71 B

Total Assets for similar companies or competitors

Company Total assets differencediff. Country
โ‚น245.92 B-23.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น1.583 T 390.03%๐Ÿ‡ฌ๐Ÿ‡ง UK
โ‚น0.37 B-99.88%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น6.838 T 2,016.73%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น11.742 T 3,534.63%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น18.539 T 5,638.46%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น111.52 B-65.48%๐Ÿ‡บ๐Ÿ‡ธ USA
โ‚น0.64 B-99.80%๐Ÿ‡บ๐Ÿ‡ธ USA